Literature DB >> 20488951

Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD.

Rama Nadella1, Joe B Blumer, Guangfu Jia, Michelle Kwon, Talha Akbulut, Feng Qian, Filip Sedlic, Tetsuro Wakatsuki, William E Sweeney, Patricia D Wilson, Stephen M Lanier, Frank Park.   

Abstract

The activation of heterotrimeric G protein signaling is a key feature in the pathophysiology of polycystic kidney diseases (PKD). In this study, we report abnormal overexpression of activator of G protein signaling 3 (AGS3), a receptor-independent regulator of heterotrimeric G proteins, in rodents and humans with both autosomal recessive and autosomal dominant PKD. Increased AGS3 expression correlated with kidney size, which is an index of severity of cystic kidney disease. AGS3 expression localized exclusively to distal tubular segments in both normal and cystic kidneys. Short hairpin RNA-induced knockdown of endogenous AGS3 protein significantly reduced proliferation of cystic renal epithelial cells by 26 +/- 2% (P < 0.001) compared with vehicle-treated and control short hairpin RNA-expressing epithelial cells. In summary, this study suggests a relationship between aberrantly increased AGS3 expression in renal tubular epithelia affected by PKD and epithelial cell proliferation. AGS3 may play a receptor-independent role to regulate Galpha subunit function and control epithelial cell function in PKD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488951      PMCID: PMC2938587          DOI: 10.1681/ASN.2009121224

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

1.  Identification of a truncated form of the G-protein regulator AGS3 in heart that lacks the tetratricopeptide repeat domains.

Authors:  N Pizzinat; A Takesono; S M Lanier
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

Review 2.  Heterotrimeric G-protein betagamma-dimers in growth and differentiation.

Authors:  W F Schwindinger; J D Robishaw
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

3.  Efficient lentiviral transduction of liver requires cell cycling in vivo.

Authors:  F Park; K Ohashi; W Chiu; L Naldini; M A Kay
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

4.  The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein.

Authors:  Christopher J Ward; Marie C Hogan; Sandro Rossetti; Denise Walker; Tam Sneddon; Xiaofang Wang; Vicky Kubly; Julie M Cunningham; Robert Bacallao; Masahiko Ishibashi; Dawn S Milliner; Vicente E Torres; Peter C Harris
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

5.  Selective interaction of AGS3 with G-proteins and the influence of AGS3 on the activation state of G-proteins.

Authors:  M L Bernard; Y K Peterson; P Chung; J Jourdan; S M Lanier
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

6.  Receptor-independent activators of heterotrimeric G-protein signaling pathways.

Authors:  A Takesono; M J Cismowski; C Ribas; M Bernard; P Chung; S Hazard; E Duzic; S M Lanier
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

7.  Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2.

Authors:  Patrick Delmas; Hideki Nomura; Xiaogang Li; Montaha Lakkis; Ying Luo; Yoav Segal; Jose M Fernández-Fernández; Peter Harris; Anna-Maria Frischauf; David A Brown; Jing Zhou
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

8.  Polycystic kidney disease: from the bedside to the gene and back.

Authors:  J J Grantham
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-07       Impact factor: 2.894

9.  Activator of G protein signaling 3 is a guanine dissociation inhibitor for Galpha i subunits.

Authors:  L De Vries; T Fischer; H Tronchère; G M Brothers; B Strockbine; D P Siderovski; M G Farquhar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

10.  Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD.

Authors:  W E Sweeney; L Kusner; C R Carlin; S Chang; L Futey; C U Cotton; K M Dell; E D Avner
Journal:  Am J Physiol Cell Physiol       Date:  2001-11       Impact factor: 4.249

View more
  28 in total

Review 1.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

2.  Role of G-proteins and phosphorylation in the distribution of AGS3 to cell puncta.

Authors:  Ali Vural; Ersin Fadillioglu; Fatih Kelesoglu; Dzwokai Ma; Stephen M Lanier
Journal:  J Cell Sci       Date:  2018-12-05       Impact factor: 5.285

3.  G-protein βγ subunit dimers modulate kidney repair after ischemia-reperfusion injury in rats.

Authors:  Sarah M White; Lauren M North; Emily Haines; Megan Goldberg; Lydia M Sullivan; Jeffrey D Pressly; David S Weber; Frank Park; Kevin R Regner
Journal:  Mol Pharmacol       Date:  2014-07-15       Impact factor: 4.436

4.  Direct Coupling of a Seven-Transmembrane-Span Receptor to a Gαi G-Protein Regulatory Motif Complex.

Authors:  William G Robichaux; Sukru S Oner; Stephen M Lanier; Joe B Blumer
Journal:  Mol Pharmacol       Date:  2015-05-13       Impact factor: 4.436

5.  Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4).

Authors:  William G Robichaux; Melissa Branham-O'Connor; Il-Young Hwang; Ali Vural; Johne H Kehrl; Joe B Blumer
Journal:  J Pharmacol Exp Ther       Date:  2017-01-06       Impact factor: 4.030

Review 6.  Activators of G protein signaling in the kidney.

Authors:  Frank Park
Journal:  J Pharmacol Exp Ther       Date:  2015-01-27       Impact factor: 4.030

7.  Intersection of two key signal integrators in the cell: activator of G-protein signaling 3 and dishevelled-2.

Authors:  Ali Vural; Stephen M Lanier
Journal:  J Cell Sci       Date:  2020-09-04       Impact factor: 5.285

8.  Activator of G protein signaling 3 forms a complex with resistance to inhibitors of cholinesterase-8A without promoting nucleotide exchange on Gα(i3).

Authors:  Man K Tse; Christina J Morris; Mingjie Zhang; Yung H Wong
Journal:  Mol Cell Biochem       Date:  2014-12-06       Impact factor: 3.396

Review 9.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

10.  Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3).

Authors:  Melissa Branham-O'Connor; William G Robichaux; Xian-Kui Zhang; Hyeseon Cho; John H Kehrl; Stephen M Lanier; Joe B Blumer
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.